Protein Potential LLC

Rockville, MD 20850
http://www.proteinpotential.com
9 Employees

SBIR Award Summary

Total Number of Awards 24
Total Value of Awards $9.67MM
First Award Date 02/15/04
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
Sim Dr. Kim Lee Sim 1 Message
Sim B. Kim Lee Sim 23

24 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 08/01/17 - 07/31/18

Enteric diseases caused by enterotoxigenic E. coli (ETEC) strains, Shigella spp, and Salmonella Typhi, all of which are NIAID Category B priority agents, collectively affect > 400 million people annually worldwide. Currently, there is no vaccine against ETEC or shigellosis. A typhoid vaccine exists. An affordable, effective, oral multivalent vac...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 08/18/16 - 07/31/17

Enteric diseases caused by enterotoxigenic E. coli (ETEC) strains, Shigella spp, and Salmonella Typhi, all ofwhich are NIAID Category B priority agents, collectively affect > 400 million people annually worldwide.Currently, there is no vaccine against ETEC or shigellosis. A typhoid vaccine exists. An affordable, effective,oral multivalent vaccin...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/16 - 02/28/17

? DESCRIPTION (provided by applicant): Vaccines are a rational and cost-effective means for protecting against infectious diseases in travelers, military personnel, and in endemic developing country populations. Our goal in this proposal is to address several significant vaccine needs: 1) the need for an easy-to-administer (needle-free) and ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/15 - 02/29/16

DESCRIPTION (provided by applicant): Vaccines are a rational and cost-effective means for protecting against infectious diseases in travelers, military personnel, and in endemic developing country populations. Our goal in this proposal is to address several significant vaccine needs: 1) the need for an easy-to-administer (needle-free) and safe ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 07/01/13 - 06/30/14

DESCRIPTION (provided by applicant): Malaria causes at least 250 million cases and nearly 1 million deaths per year. GSK's malaria vaccine, RTS, S/AS01 is being tested in a Phase 3 clinical trial, and is likely to be licensed for use in children in the developing world, if safe ad effective. This vaccine is based entirely on the repeat region an...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 06/01/13 - 05/31/14

DESCRIPTION (provided by applicant): Malaria caused by Plasmodium falciparum (Pf) results in more than 250 million clinical cases, and nearly one million deaths annually. A vaccine would be the ideal intervention for reducing malaria morbidity and mortality. All clinical manifestations and pathology of malaria are caused by the erythrocytic stag...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 06/01/13 - 05/31/14

DESCRIPTION (provided by applicant): We believe that eradication of malaria is achievable but not without a potent vaccine that interrupt malaria transmission (VIMT) transmission blocking vaccine. A logical and promising strategy is to combine target antigens from multiple stages to potently prevent transmission. To prevent transmission a vaccin...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 07/01/12 - 06/30/13

DESCRIPTION (provided by applicant): Malaria causes at least 250 million cases and nearly 1 million deaths per year. GSK's malaria vaccine, RTS, S/AS01 is being tested in a Phase 3 clinical trial, and is likely to be licensed for use in children in the developing world, if safe ad effective. This vaccine is based entirely on the repeat region an...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 06/20/12 - 05/31/13

DESCRIPTION (provided by applicant): We believe that eradication of malaria is achievable but not without a potent vaccine that interrupt malaria transmission (VIMT) transmission blocking vaccine. A logical and promising strategy is to combine target antigens from multiple stages to potently prevent transmission. To prevent transmission a vaccin...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 06/15/12 - 05/31/13

DESCRIPTION (provided by applicant): Malaria caused by Plasmodium falciparum (Pf) results in more than 250 million clinical cases, and nearly one million deaths annually. A vaccine would be the ideal intervention for reducing malaria morbidity and mortality. All clinical manifestations and pathology of malaria are caused by the erythrocytic stag...

Load More